Found 14 matching trials
Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT PHASE2 The purpose of this study is to evaluate the safety and efficacy of Melphal...
Show More Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Learn More & Join Trial
High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma PHASE2 The involvement of the central nervous system (CNS) by non-Hodgkin lymphoma...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Tandem Auto-Allo Transplant for Lymphoma PHASE2 Relapse remains a principle cause of treatment failure for patients with ag...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies PHASE1 The purpose of this study is to test the safety of giving the patient speci...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT PHASE2 The purpose of this study is to determine if double autologous then allogen...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG PHASE2 To evaluate the toxicity and tolerability of this tandem autologous/allogen...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma PHASE2 Mixed chimerism transplantation is an approach to allogeneic transplants th...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT PHASE2 The purpose of this study is to evaluate the safety and efficacy of BUCY+VP...
Show More Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Learn More & Join Trial
IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT PHASE2 Autologous hematopoietic stem cell transplantation (Auto-HSCT) is an effect...
Show More Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Learn More & Join Trial
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors NA This is a standard of care treatment guideline for high risk or relapsed so...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial